Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/22/2002 | US6340673 Administering at or near a site of a tumor of tumorigenic disease a herpes simplex virus vector lacking an expressible .gamma..sub.1 34.5 gene, whereby the growth of tumor is suppressed |
01/22/2002 | US6340668 Administering bone morphogenetic protein-11 (bmp-11) to neuronal cells effective to promote the survival of cells |
01/22/2002 | US6340595 A library of unique expressible nucleic acids within a multiplicity of compartments consisting of adenoviral vectors that are introduced into replication defective host cells; for determining functions of nucleic acid sequences |
01/22/2002 | US6340593 Plant-optimized polynucleotides encoding approximately 15 kDa and approximately 45 kDa pesticidal proteins |
01/22/2002 | US6340592 Human cell lines |
01/22/2002 | US6340591 Integrative protein-DNA cochleate formulations and methods for transforming cells |
01/22/2002 | US6340579 Gene encoding an alpha-hydroxy-gamma-carboxymuconic acid-epsilon-semialdehyde dehydrogenase |
01/22/2002 | US6340577 Protein fragments for use in protein targeting |
01/22/2002 | US6340575 An isolated nucleic acid encoding a ras superfamily, rac gene, that modulates gtpase activity; cancer therapy |
01/22/2002 | US6340574 Regulated autocrine growth of mammalian cells |
01/22/2002 | US6340571 Antibodies specific for Staphylococcus aureus, and use thereof |
01/22/2002 | US6340570 Detection and characterization of microorganisms |
01/22/2002 | US6340569 Monoclonal antibody and antigens specific therefor and methods of using same |
01/22/2002 | US6340568 Method for detecting and classifying nucleic acid hybridization |
01/22/2002 | US6340565 Determining signal transduction pathways |
01/22/2002 | US6340563 Obtaining a histological tissue sample and analyzing under the microscope to target and select a sample that has pathological characteristics, obtaining dna sequences from the target sample, amplifying the dna and detecting mutations |
01/22/2002 | US6340462 For inducing immunological response in a vertebrate to pathogen by inoculating with synthetic recombinant avipox virus modified by presence, in non-essential region of avipox genome, of dna from any source which encodes for antigen |
01/22/2002 | US6340459 Administering to agent capable of inhibiting interaction between cd40 ligand and the cells to inhibit activation of the cells in therapy of reperfusion injury, in an non-transplant recipient |
01/22/2002 | CA2259962C Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
01/22/2002 | CA2149333C Eck receptor ligands |
01/22/2002 | CA2050304C Pharmaceutical composition useful in preventing or treating tumors induced by papillomaruses |
01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
01/22/2002 | CA1341333C Amylin peptides and uses thereof |
01/21/2002 | CA2313449A1 Engineering salt tolerance in crop plants |
01/18/2002 | CA2349743A1 Diagnostic assay |
01/17/2002 | WO2002005205A2 Method and system for modeling biological systems |
01/17/2002 | WO2002004956A2 Method of identifying conformation-sensitive binding peptides and uses thereof |
01/17/2002 | WO2002004953A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
01/17/2002 | WO2002004952A2 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
01/17/2002 | WO2002004948A2 Distinguishing molecular forms |
01/17/2002 | WO2002004681A2 Method of detection by enhancement of silver staining |
01/17/2002 | WO2002004680A2 Real-time sequence determination |
01/17/2002 | WO2002004675A1 Haplotypes of the kcnb1 gene |
01/17/2002 | WO2002004674A2 Transposon mediated multiplex sequencing |
01/17/2002 | WO2002004672A2 Diagnostic method for the identification of foetal dna in a maternal sample |
01/17/2002 | WO2002004671A2 Improved binding interactions in dipstick assays |
01/17/2002 | WO2002004670A2 Improved capture and detection of target nucleic acid in dipstick assays |
01/17/2002 | WO2002004669A2 Improved capture and detection format versatility for dipstick assays |
01/17/2002 | WO2002004668A2 Improved capture and detection of target nucleic acid in dipstick assays |
01/17/2002 | WO2002004667A2 Improved detection signal and capture in dipstick assays |
01/17/2002 | WO2002004665A2 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors |
01/17/2002 | WO2002004656A2 Bio-probes and use thereof |
01/17/2002 | WO2002004655A2 Cation mediated triplex hybridization assay |
01/17/2002 | WO2002004653A2 Sinapoylglucose : malate sinapoyltransferase forms malate conjugates from benozic acid glucosides |
01/17/2002 | WO2002004651A2 Jointless gene of tomato |
01/17/2002 | WO2002004650A2 Methods for maximizing expression of transgenic traits in autopolyploid plants |
01/17/2002 | WO2002004649A2 Methods for enhancing plant transformation frequencies |
01/17/2002 | WO2002004647A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
01/17/2002 | WO2002004646A1 Expression system |
01/17/2002 | WO2002004645A2 A second human heparanase, and splice variants thereof, with a predominant expression in skeletal muscle, heart and pancreas |
01/17/2002 | WO2002004644A2 Aspartylprotease |
01/17/2002 | WO2002004643A1 Tumor necrosis factor-gamma |
01/17/2002 | WO2002004642A1 Novel polypeptide and dna thereof |
01/17/2002 | WO2002004641A1 Novel g protein-coupled receptor protein and dna thereof |
01/17/2002 | WO2002004640A1 Novel g protein-coupled receptor protein and dna thereof |
01/17/2002 | WO2002004639A1 Novel g protein-coupled receptor protein and dna thereof |
01/17/2002 | WO2002004638A1 Compounds targeted to cellular locations |
01/17/2002 | WO2002004637A1 Myocardium-specific promoter |
01/17/2002 | WO2002004636A1 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |
01/17/2002 | WO2002004635A1 A novel polypeptide, a human mbll zinc finger protein 39 and the polynucleotide encoding the polypeptide |
01/17/2002 | WO2002004634A1 A novel polypeptide, a human apoptosis relative protein 9.46 and the polynucleotide encoding the polypeptide |
01/17/2002 | WO2002004633A1 A novel polypeptide, a human fascicular and elongation protein 12.87 and the polynucleotide encoding the polypeptide |
01/17/2002 | WO2002004632A1 A novel polypeptide, a human latexin protein 53 and the polynucleotide encoding the polypeptide |
01/17/2002 | WO2002004631A1 A novel polypeptide, a human l1 factor orf2 inverse transcription relative protein 11 and the polynucleotide encoding the polypeptide |
01/17/2002 | WO2002004630A2 Methods for recombinatorial nucleic acid synthesis |
01/17/2002 | WO2002004629A2 Molecular breeding of transposable elements |
01/17/2002 | WO2002004628A2 Method of identifying a binding partner of a gene product |
01/17/2002 | WO2002004624A1 Novel g protein-coupled receptor protein and dna thereof |
01/17/2002 | WO2002004623A2 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
01/17/2002 | WO2002004622A2 Transgenic mice containing cx2 gene disruptions |
01/17/2002 | WO2002004621A2 Methods of creating constructs useful for introducing sequences into embryonic stem cells |
01/17/2002 | WO2002004620A2 Method for isolating nucleic acids |
01/17/2002 | WO2002004619A2 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target |
01/17/2002 | WO2002004617A2 Novel cacao endoproteinases and their use in the production of cocoa flavour |
01/17/2002 | WO2002004616A1 RECOMBINANT α-L-IDURONIDASE, METHODS FOR PRODUCING AND PURIFYING THE SAME AND METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES THEREOF |
01/17/2002 | WO2002004614A2 Genes encoding sinapoylglucose: malate sinapoyltransferase and methods of use |
01/17/2002 | WO2002004613A2 Isolated polynucleotides encoding human 5'-nucleotide cn-ia and cn-ib, isolated proteins encoded by the same, and methods utilizing the same |
01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
01/17/2002 | WO2002004611A2 Aminoacyl trna synthetases |
01/17/2002 | WO2002004609A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
01/17/2002 | WO2002004607A1 Human myeloma cell line |
01/17/2002 | WO2002004605A2 Stimulation of cellular regeneration and differentiation in the inner ear |
01/17/2002 | WO2002004602A1 Transformed yeast presenting protein a on the cell surface layer |
01/17/2002 | WO2002004601A2 Mammalian mdm2 binding proteins and uses thereof |
01/17/2002 | WO2002004600A2 Novel compounds |
01/17/2002 | WO2002004599A2 Placental protein having multiple egf-like domains |
01/17/2002 | WO2002004595A2 Production of chimeric human papillomavirus |
01/17/2002 | WO2002004555A1 Superparamagnetic pearl polymers |
01/17/2002 | WO2002004523A2 Artificial antibody polypeptides |
01/17/2002 | WO2002004522A2 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
01/17/2002 | WO2002004520A2 Transporters and ion channels |
01/17/2002 | WO2002004519A2 Murine cytokine receptor |
01/17/2002 | WO2002004518A2 Human neuropeptide y-like g protein-coupled receptor |
01/17/2002 | WO2002004517A1 A putative g-protein coupled receptor for gamma butyric acid (gab9) |
01/17/2002 | WO2002004514A2 Compositions and methods for the therapy and diagnosis of lung cancer |
01/17/2002 | WO2002004513A2 Down syndrome critical region 1-like 1 proteins |
01/17/2002 | WO2002004511A2 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
01/17/2002 | WO2002004510A2 Gtp-binding proteins |
01/17/2002 | WO2002004509A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
01/17/2002 | WO2002004506A1 A new polypeptide- human rna binding protein 19 and the polynucleotide encoding it |